After Decades of exploiting the restorative properties of hyaluronic acid (HA) for use in cosmetics and nutraceuticals, companies are now moving into the raidly growing market for HA-based pharmaceutical products and medical devices. Denmark-based Novozymes A/S in the most recent to invest in HA capabilities, expanding outside of its stable of enzymes into what it believes will be a complementary new niche.
展开▼
机译：在利用透明质酸（HA）的化妆品和营养食品的修复特性进行了数十年的发展之后，公司现在正进入以HA为基础的药品和医疗设备的快速增长的市场。总部位于丹麦的Novozymes A / S最近投资于HA功能，将其酶稳定剂以外的产品扩展到它认为将成为补充性的新利基市场。
展开▼
